Nongenomic actions of steroid hormones

Nature Reviews Molecular Cell Biology

Volumn 4, Issue 1, 2003, Pages 46-56

  Lösel, Ralf ^a   Wehling, Martin ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA ESTRADIOL; 4 AMINOBUTYRIC ACID; ALDOSTERONE; ANTIESTROGEN; CALCIUM ION; COLECALCIFEROL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLOHEXIMIDE; DACTINOMYCIN; DNA; ESTRADIOL; ESTROGEN; FULVESTRANT; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID; LIOTHYRONINE; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; NEUROSTEROID; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGESTERONE; PROTEIN KINASE C; STEROID; STEROID RECEPTOR; THYROID HORMONE; THYROXINE; VITAMIN D;

BINDING AFFINITY; DNA BINDING; GENOME; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HORMONE STRUCTURE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; STEROIDS;

EID: 0037224484     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm1009     Document Type: Review

References (123)

1. Selye, H. Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology 30, 437-453 (1942). The first detailed report of rapid steroid action in addition to a delayed action - a fine example of careful scientific work that was unbiased by preconceived ideas.
2. Klein, K. & Henk, W. Klinisch-experimentelle Untersuchungen über den Einfluβ von Aldosteron auf Hämodynamik und Gerinnung. Z. Kreisl. Forsch. 52, 40-53 (1963).
3. Spach, C. & Streeten, D. H. Retardation of sodium exchange in dog erythrocytes by physiological concentrations of aldosterene, in vitro. J. Clin. Invest. 43, 217-227 (1964).
4. Beato, M. Gene regulation by steroid hormones. Cell 56, 335-344 (1989). An excellent account of the direct genomic action of classical steroid receptors.
5. Losel, R. M. et al. Nongenomic steroid action: controversies, questions and answers? Physiol. Rev. (in the press).
6. Meyer, C., Schmid, R., Scriba, P. C. & Wehling, M. Purification and partial sequencing of high affinity progesterone-binding site(s) from porcine liver membranes. Eur. J. Biochem. 239. 726-731 (1996).
7. Falkenstein, E., Norman, A. W. & Wehling, M. Mannheim classification of nongenomically initiated (rapid) steroid action(s). J Clin. Endocrinol Metab. 85, 2072-2075 (2000). The classification scheme outlined in this work should enable nongenomic responses to be categorized.
8. Masui, Y. & Markert, C. L. Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes. J. Exp. Zool. 177, 129-145 (1971).
9. Finidori-Lepicard, J., Schorderet-Slatkine, S., Hanoune, J. & Baulieu, E. E. Progesterone inhibits membrane-bound adenylate cyclase in Xenopus laevis oocytes. Nature 292, 255-257 (1981).
10. Sadler, S. E. & Maller, J. L. Progesterone inhibits adenylate cyclase in Xenopus oocytes. Action on the guanine nucleotide regulatory protein. J. Biol. Chem. 256, 6368-6373 (1981).
11. Maller, J. L. & Krebs, E. G. Progesterone-stimulated meiotic cell division in Xenopus oocytes. Induction by regulatory subunit and inhibition by catalytic subunit of adenosine 3′:5′-monophosphate-dependent protein kinase. J. Biol. Chem. 252, 1712-1718 (1977).
12. Bagowski, C. P., Myers, J. W. & Ferrell, J. E. Jr. The classical progesterone receptor associates with p42 MAPK and is involved in phosphatidylinositol 3-kinase signaling in Xenopus oocytes. J. Biol. Chem. 276, 37708-37714 (2001).
13. Osman, R. A., Andria, M. L., Jones, A. D. & Meizel, S. Steroid induced exocytosis: the human sperm acrosome reaction. Biochem. Biophys. Res. Commun. 160, 828-833 (1989). This study reports on the identification of progesterone as an acrosome-reaction-inducing compound present in human follicular fluid.
14. , Meizel, S. & Turner, K. O. Progesterone acts at the plasma membrane of human sperm. Mol. Cell. Endocrinol. 77, R1-R5 (1991).
15. Castilla, J. A. et al. Undetectable expression of genomic progesterone receptor in human spermatozoa. Hum. Reprod. 10, 1757-1760 (1995).
16. Luconi, M. et al. Identification and characterization of functional nongenomic progesterone receptors on human sperm membrane. J. Clin. Endocrinol. Metab. 83, 877-885 (1998).
17. Sabeur, K. Edwards, D. P. & Meizel, S. Human sperm plasma membrane progesterone receptor(s) and the acrosome reaction. Biol. Reprod. 54, 993-1001 (1996).
18. Sachdeva, G., Shah, C. A., Kholkute, S. D. & Puri, C. P. Detection of progesterone receptor transcript in human spermatozoa. Biol Reprod. 62, 1610-1614 (2000).
19. Blackmore, P. F., Fisher, J. F., Spilman, C. H. & Bleasdale, J. E. Unusual steroid specificity of the cell surface progesterone receptor on human sperm. Mol. Pharmacol. 49, 727-739 (1996). The differences in steroid selectivity between the classical and the nonclassical sperm progesterone receptors have been studied with a large set of steroids.
20. Blackmore, P. F., Neulen, J., Lattanzio, F., & Beebe, S. J. Cell surface-binding sites for progesterone mediate calcium uptake in human sperm. J. Biol. Chem. 268, 18655-18659 (1991).
21. Baldi, E. et al. Intracellular calcium accumulation and responsiveness to progesterone in capacitating human spermatozoa. J. Androl. 12, 323-330 (1991).
22. Serres, C., Yang, J. & Jouannet, P. RU486 and calcium fluxes in human spermatozoa. Biochem. Biophys. Res. Commun. 204, 1009-1015 (1994).
23. Blackmore, P. F. & Lattanzio, F. A. Cell surface localization of a novel non-genomic progesterone receptor on the head of human sperm. Biochem Biophys. Res. Commun. 181, 331-336 (1991).
24. 2+-fluxes in sperm. Endocrinology 140, 5999-6002 (1999).
25. Falkenstein, E., Meyer, C., Eisen, C., Scriba, P. C. & Wehling, M. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 229, 86-89 (1996).
26. Krebs, C. J., Jarvis, E. D., Chan, J., Lydon, J. P., Ogawa, S. & Pfaff, D. W. A membrane-associated progesterone-binding protein, 25-Dx, is regulated by progesterone in brain regions involved in female reproductive behaviors. Proc. Natl Acad. Sci. USA 97, 12816-12821 (2000).
27. Boonyaratanakornkit, V. et al. Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol. Cell 8, 269-280 (2001).
28. Pietras, R. J. & Szego, C. M. Endometrial cell calcium and oestrogen action. Nature 253, 357-359 (1975).
29. 2+ entry in human endometrial cells. Mol. Cell. Endocrinol. 176, 77-84 (2001).
30. Morley, P., Whitfield, J. F., Vanderhyden, B. C., Tsang, B. K. & Schwartz, J. L. A new, nongenomic estrogen action: the rapid release of intracellular calcium. Endocrinology 131, 1305-1312 (1992).
31. Tesarik, J. & Mendoza, C. Nongenomic effects of 17β-estradiol on maturing human occytes: relationship to oocyte developmental potential. J. Clin. Endocrinol. Metab. 80, 1438-1443 (1995).
32. Pietras, R. J. & Szego, C. M. Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 265, 69-72 (1977).
33. Reis, S. E. et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89, 52-60 (1994).
34. Salas, E. et al. Endothelium-independent relaxation by 17-α-estradiol of pig coronary arteries. Eur. J. Pharmacol. 258, 47-55 (1994).
35. Shaul, P. W. Rapid activation of endothelial nitric oxide synthase by estrogen. Steroids 64, 28-34 (1999). An overview of the essential properties of NOS activation by oestradiol.
36. 2+ mobilization. Circ. Res. 81, 885-892 (1997).
37. Chen, Z. et al. Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103, 401-406 (1999).
38. Haynes, M. P. et al. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res. 87, 677-682 (2000).
39. Wyckoff, M. H. et al. Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Gα(i). J. Biol. Chem. 276, 27071-27076 (2001).
40. Russell, K. S., Haynes, M. P., Shina, D., Clensme, E. & Bender, J. R. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc. Natl Acad. Sci. USA 97, 5930-5935 (2000).
41. Rasandi, M., Oh, P., Pedram, A., Schnitzer, J. & Levin, E. R. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol. Endocrinol. 16, 100-115 (2002).
42. Chambliss, K. L. et al. Estrogen receptor α and endothelial nitric oxide synthase are organized into a functional signaling module in caveclae. Circ. Res. 87, E44-E52 (2000).
43. Toran-Allerand, C. D., Singh, M. & Setalo, G. Jr. Novel mechanisms of estrogen action in the brain: new players in an old story. Front. Neuroendocrinol. 20, 97-121 (1999).
44. Chambliss, K. L., Yuhanna, I. S. Anderson, R. G., Mendelsohn, M. E. & Shaul, P. W. ERβ has nongenomic action in caveolae. Mol. Endocrinol. 16, 938-946 (2002).
45. Shughrue, P. J., Askew, G. R. Dellovade, T. L. & Merchenthaler, I. Estrogen-binding sites and their functional capacity in estrogen receptor double knockout mouse brain. Endocrinology 143, 1643-1650 (2002).
46. Pedram, A., Razandi, M., Aitkenhead, M., Hughes, C. C. & Levin, E. R. Integration of the non-genomic and genomic actions of estrogen: membrane initiated signaling by steroid (MISS) to transcription and cell biology. J. Biol Chem. (in the press).
47. Wehling, M., Armanini, D., Strasser, T. & Weber, P. C. Effect of aldosterone on sodium and potassium concentrations in human mononuclear leukocytes. Am. J. Physiol. 252, E505-E508 (1987).
48. Wehling, M., Käsmayr, J. & Theisen, K. Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway? Am. J. Physiol. 260, E719-E726 (1991).
49. Wehling, M., Kuhls, S. & Armanini, D. Volume regulation of human lymphocytes by aldosterone in isotonic media. Am. J. Physiol. 257, E170-E174 (1989).
50. Wehling, M., Ulsenheimer, A., Schneider, M., Neylon, C. & Christ, M. Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: subcellular localization of calcium elevations by single cell imaging. Biochem. Biophys. Res. Commun. 204, 475-481 (1994).
51. Wehling, M. Specific, nongenomic actions of steroid hormones. Annu. Rev. Physiol. 59, 365-393 (1997).
52. Haseroth, K. et al. Rapid nongenomic effects of aldosterone in mineralcoorticoid-receptor-knockout mice. Biochem. Biophys. Res. Commun. 266, 257-261 (1999).
53. Alzamora, R., Michea, L. & Marusic, E. T. Role of 11β-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension 35, 1099-1104 (2000).
54. Peterfalvi, M., Torelli, V., Fournex, R., Rousseau, G., Claire, M., Michaud, A. & Corvol, P. Importance of the lactonic ring in the activity of steroidal antialdosterones. Biochem. Pharmacol. 29, 353-357 (1980).
55. Estrada, M., Liberona, J. L., Miranda, M. & Jaimovich, E. Aldosterone- and testosterone-mediated intracellular calcium response in skeletal muscle cell cultures. Am. J. Physiol. Endocrinol. Metab. 279, E132-E139 (2000).
56. 2+ in M-1 cortical collecting duct cells. Kidney Int. 57, 1395-1403 (2000).
57. Oberleithner, H. Aldosterone and nuclear signaling in kidney. Steroids 64, 42-50 (1999).
58. Barbato, J. C., Mulrow, P. J., Shapiro, J. I. & Franco-Saenz, R. Rapid effects of aldosterone and spironolactone in the isolated working rat heart. Hypertension 40, 130-135 (2002). In this paper, aldosterone and spironolactone are shown to rapidly modulate cardiac function, which might have significance for cardiac diseases.
59. Orchinik, M., Murray, T. F. & Moore, F. L. A corticosteroid receptor in neuronal membranes. Science 252, 1848-1851 (1991).
60. Moore, F. L. Amphibian model system for problems in behavioral neuroendocrinology. J. Exp. Zool. Suppl. 4, 157-158 (1990).
61. Evans, S. J., Searcy, B. T. & Moore, F. L. A subset of κ opioid ligands bind to the membrane glucocorticoid receptor in an amphibian brain. Endocrinology 141, 2294-2300 (2000).
62. Evans, S. J., Murray, T. F. & Moore, F. L. Partial purification and biochemical characterization of a membrane glucocorticoid receptor from an amphibian brain. J. Steroid Biochem. Mol. Biol. 72, 209-221 (2000).
63. Hinz, B. & Hirschelmann, R. Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Pharm. Res. 17, 1273-1277 (2000).
64. Buttgereit, F., Burmester, G. R. & Brand, M. D. Bioenergetics of immune functions: fundamental and therapeutic aspects. Immunol. Today 21, 192-199 (2000).
65. Gametchu, B. Glucocorticoid receptor-like antigen in lymphoma cell membranes: correlation to cell lysis. Science 236, 456-461 (1987).
66. Gametchu, B., Watson, C. S. & Wu, S. Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. FASEB J. 7, 1283-1292 (1993).
67. Watson, C. S. & Gametchu, B. Membrane estrogen and glucocorticoid receptors - implications for hormonal control of immune function and autoimmunity. Int. Immunopharmacol. 1, 1049-1063 (2001).
68. Buttgereit, F., Brand, M. D. & Burmester, G. R. Equivalent doses and relative drug potencies for non-genomic glucocorticoid effects: a novel glucocorticoid hierarchy. Biochem. Pharmacol. 58, 363-368 (1999).
69. Hafezi-Moghadam, A. et al. Acute cardiovascular protective effects of corticosteroids are mediated by nontranscriptional activation of endothelial nitric oxide synthase. Nature Med 8, 473-479 (2002).
70. 3. Endocrinology 115, 1476-1483 (1984).
71. 3. J. Biol. Chem. 268, 20022-20030 (1993). This is the first description of a selective antagonist for nongenomic vitamin D responses.
72. 3. Steroids 64, 120-128 (1999).
73. 3 signal response pathways in osteoblasts: cross-talk between genomic and membrane-initiated pathways. Am. J. Kidney Dis 31, 729-742 (1998).
74. 3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses. Steroids 66, 147-158 (2001).
75. 3 regulate chondrocyte proliferation and proteoglycan production as well as protein kinase C through a nongenomic pathway. J. Cell Biochem. 66, 457-470 (1997).
76. 3 with low affinity for the vitamin D receptor modulate chondrocytes via membrane effects that are dependent on cell maturation. J. Cell Physiol. 171, 357-367 (1997).
77. 3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. J. Biol. Chem. 262, 13168-13173 (1987).
78. 3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J. Biol. Chem. 264, 20265-20274 (1989).
79. Civitelli, R. et al. Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells. Endocrinology 127, 2253-2262 (1990).
80. 3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor. J. Bone Miner. Res. 6, 1269-1275 (1991).
81. Le Mellay, V., Grosse, B. & Lieberherr, M. Phospholipase Cβ and membrane action of calcitriol and estradiol. J. Biol. Chem. 272, 11902-11907 (1997).
82. 3. J. Cell. Physiol. 167, 380-393 (1996).
83. 3 stimulates membrane phosphoinositide turnover, activates protein kinase C, and increases cytosolic calcium in rat colonic epithelium. J. Clin. Invest. 85, 1296-1303 (1990).
84. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem. Biophys. Res. Commun. 241, 419-426 (1997).
85. 3-mediated rapid stimulation of intestinal calcium transport, (transcaltachia). Endocrinology 127, 39-45 (1990).
86. 3 of the adenylyl cyclase/cyclic AMP pathway in rat and chick myoblasts. Biochim. Biophys. Acta 1269, 91-97 (1995).
87. 3. Calcif. Tissue Int. 47, 314-319 (1990).
88. 3 in cardiac muscle. Mol. Cell. Endocrinol. 82, 229-235 (1991).
89. 3 stimulation of calcium uptake by rat intestinal cells involves a dihydropyndine-sensitive cAMP-dependent pathway. Cell Signal. 6, 299-304 (1994).
90. 3H)glucose uptake in cultured chick embryo heart cells. Endocrinology 101, 143-149 (1977).
91. Segal, J. A rapid, extranuclear effect of 3,5,3′-triiodothyronine on sugar uptake by several tissues in the rat in vivo. Evidence for a physiological role for the thyroid hormone action at the level of the plasma membrane. Endocrinology 124, 2755-2764 (1989).
92. Segal, J. In vivo effect of 3,5,3′-triiodothyronine on calcium uptake in several tissues in the rat: evidence for a physiological role for calcium as the first messenger for the prompt action of thyroid hormone at the level of the plasma membrane. Endocrinology 127, 17-24 (1990).
93. 2+-ATPase activity in vitro Correlations between hormone structure and biological activity in a human cell system. J. Biol. Chem. 258, 12373-12377 (1983).
94. Rubinacci, A., Divieti, P., Lodigiani, S., De Ponti, A. & Samaja, M. Thyroid hormones and active calcium transport of inside-out red cell membrane vesicles. Biochem. Med. Metab. Biol. 48, 235-240 (1992).
95. 2+-ATPase activity. Endocr. Res. 15, 651-682 (1989).
96. Lawrence, W. D., Schoenl, M. & Davis, P. J. Stimulation in vitro of rabbit erythrocyte cytosol phospholipid-dependent protein kinase activity. A novel action of thyroid hormone. J. Biol. Chem. 264, 4766-4768 (1989).
97. Lin, H. Y., Thacorf, H. R., Davis, F. B. & Davis, P. J. Potentiation by thyroxine of interferon-γ-induced antiviral state requires PKA and PKC activities. Am. J. Physiol. 271, C1256-C1261 (1996).
98. Kavok, N. S., Krasilnikova, O. A. & Babenko, N. A. Thyroxine signal transduction in liver cells involves phospholipase C and phospholipase D activation. Genomic independent action of thyroid hormone. BMC Cell. Biol. 2, 5 (2001).
99. Lin, H. Y., Davis, F. B., Gordinier, J. K., Martino, L. J. & Davis, P. J. Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells. Am. J. Physiol. 216, C1014-C1024 (1999).
100. Lin, H. Y., Shih, A., Davis, F. B. & Davis, P. J. Thyroid hormone promotes the phosphorylation of STAT3 and potentiates the action of epidermal growth factor in cultured cells. Biochem. J. 338, 427-432 (1999).
101. Davis, P. J., Shih, A. Lin, H. Y., Martino, L. J. & Davis, F. B. Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes senne phosphorylation of TR. J. Biol. Chem. 275, 38032-38039 (2000).
102. Ashizawa, K., McPhie, P., Lin, K. H. & Cheng, S. Y. An in vitro novel mechanism of regulating the activity of pyruvate kinase M2 by thyroid hormone and fructose 1,6-bisphosphate. Biochemistry 30, 7105-7111 (1991).
103. Arnold, S., Goglia, F. & Kadenbach, B. 3,5-Diiodothyronine binds to subunit Va of cytochrome-c oxidase and abolishes the allosteric inhibition of respiration by ATP. Eur. J. Biochem. 252, 325-330 (1998).
104. Baulieu, E. E. Neurosteroids: a new function in the brain. Biol. Cell 71, 3-10 (1991). An early account of the origin and action of neurosteroids.
105. Friess, E., Tagaya, H., Trachsel, L., Holsboer, F. & Rupprecht, R. Progesterone-induced changes in sleep in male subjects. Am. J. Physiol. 272, E885-E891 (1997).
106. Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker J. L. & Paul, S. M. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor Science 232, 1004-1007 (1986).
107. Rupprecht, R. The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res. 31, 297-314 (1997).
108. Frye, C. A. The role of neurosteroids and nongenomic effects of progestins in the ventral tegmental area in mediating sexual receptivity of rodents. Horm. Behav. 40, 226-233 (2001).
109. Mathis, C., Paul, S. M. & Crawley, J. N. The neurosteroid pregnenolone sulfate blocks NMDA antagonist-induced deficits in a passive avoidance memory task. Psychopharmacology (Berl.) 116, 201-206 (1994).
110. Reddy, D. S., Kaur, G. & Kulkarni, S. K σ(σ-1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neurereport 9, 3069-3073 (1998).
111. Weaver, C. E. Jr, Park-Chung, M., Gibbs, T. T. & Farb, D. H. 17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res. 761, 338-341 (1997).
112. Crawley, J. N., Glowa, J. R., Majewska, M. D. & Paul, S. M. Anxiolytic activity of an endogenous adrenal steroid. Brain Res. 398, 382-385 (1986).
113. Britton, K. T., Page, M., Baldwin, H. & Koob, G. F. Anxiolytic activity of steroid anesthetic alphaxalone. J. Pharmacol. Exp. Ther. 258, 124-129 (1991).
114. Wu, F. S., Gibbs, T. T. & Farb, D. H. Inverse modulation of γ-aminobutyric acid- and glycine-induced currents by progesterone. Mol. Pharmacol. 37, 597-602 (1990).
115. Wu, F. S., Chen, S. C. & Tsai, J. J. Competitive inhibition of the glycine-induced current by pregnenolone sulfate in cultured chick spinal cord neurons. Brain Res. 750, 318-320 (1997).
116. Wu, F. S., Lai, C. P. & Liu, B. C. Non-competitive inhibition of 5-HT3 receptor-mediated currents by progesterone in rat nodose ganglion neurons. Neurosci. Lett. 278, 37-40 (2000).
117. Vasudevan, N., Kow, L. M. & Pfaff, D. W. Early membrane estrogenic effects required for full expression of slower genomic actions in a nerve cell line. Proc. Natl Acad Sci. USA 98, 12267-12271 (2001). The synergy between rapid nongenomic and delayed genomic effects of the same steroid is shown in this study.
118. Nichols, M. et al. Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription. EMBO J. 11, 3337-3346 (1992).
119. Christ, M. et al. Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells. Circulation 99, 1485-1491 (1999).
120. Rowan, B. G., Garrison, N., Weigel, N. L. & O'Malley, B. W. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol. Cell. Biol. 20, 8720-8730 (2000).
121. Schmidt, B. M. et al. Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system. J. Clin. Endocrinol. Metab. 86, 761-767 (2001).
122. Zange, J., Müller, K., Gerzer, R., Sippel, K. & Wehling, M. Nongenomic effects of aldosterone on phosphocreatine levels in human calf muscle during recovery from exercise. J. Clin. Endocrinol. Metab. 81, 4296-4300 (1996).
123. Oberleithner, H., Reinhardt, J., Schillers, H., Pagel, P. & Schneider, S. W. Aldosterone and nuclear volume cycling. Cell Physiol. Biochem. 10, 429-434 (2000).